Gachon University Gil Medical Center
π°π·South Korea
Second-Line Irinotecan vs. ILF for AGC
- First Posted Date
- 2007-08-01
- Last Posted Date
- 2007-08-01
- Lead Sponsor
- Gachon University Gil Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT00509964
- Locations
- π°π·
Gachon University Gil Medical Center, Incheon, Korea, Republic of
Topotecan for Irinotecan-Refractory SCLC
Phase 2
- Conditions
- Lung CancerRefractory to Chemotherapy
- First Posted Date
- 2007-07-18
- Last Posted Date
- 2008-03-12
- Lead Sponsor
- Gachon University Gil Medical Center
- Registration Number
- NCT00502762
- Locations
- π°π·
Gachon University Gil Medical Center, Incheon, Korea, Republic of
Opioid Rotation Versus Combination for Chronic Uncontrolled Cancer Pain
Phase 2
Completed
- Conditions
- Advanced Solid Cancers
- First Posted Date
- 2007-05-24
- Last Posted Date
- 2008-03-13
- Lead Sponsor
- Gachon University Gil Medical Center
- Target Recruit Count
- 2006
- Registration Number
- NCT00478101
Safety and Effects of Ramipril Combined With Candesartan
Phase 4
Completed
- Conditions
- Hypertension
- First Posted Date
- 2006-07-26
- Last Posted Date
- 2006-07-26
- Lead Sponsor
- Gachon University Gil Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT00356395
Irinotecan Discontinuation and Reintroduction for Advanced Colorectal Cancer
Phase 2
Terminated
- Conditions
- Colorectal NeoplasmsMetastases
- First Posted Date
- 2006-05-03
- Last Posted Date
- 2008-11-25
- Lead Sponsor
- Gachon University Gil Medical Center
- Target Recruit Count
- 72
- Registration Number
- NCT00320320
- Locations
- π°π·
Gachon University Gil Medical Center, Incheon, Korea, Republic of
ILF With/Without Cisplatin for Advanced Gastric Cancer
Phase 2
- Conditions
- Stomach Neoplasm
- First Posted Date
- 2006-05-03
- Last Posted Date
- 2007-03-12
- Lead Sponsor
- Gachon University Gil Medical Center
- Target Recruit Count
- 86
- Registration Number
- NCT00320294
- Locations
- π°π·
Gachon University Gil Medical Center, Incheon, Korea, Republic of
Second-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLC
Phase 2
- Conditions
- Non-Small Cell Lung Cancer
- First Posted Date
- 2006-04-27
- Last Posted Date
- 2008-03-12
- Lead Sponsor
- Gachon University Gil Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT00319800
- Locations
- π°π·
Gachon University Gil Medical Center, Incheon, Korea, Republic of
Weekly Versus 3-Weekly Docetaxel Plus Cisplatin for Advanced NSCLC
Phase 2
Completed
- Conditions
- Advanced Non-Small Cell Lung Cancer
- First Posted Date
- 2006-04-27
- Last Posted Date
- 2008-03-12
- Lead Sponsor
- Gachon University Gil Medical Center
- Target Recruit Count
- 78
- Registration Number
- NCT00319514
- Locations
- π°π·
Gachon University Gil Medical Center, Incheon, Korea, Republic of